Enabling People to Live Well with Dementia | Pharmacological Interventions in Dementia Care



This session will investigate the most common medications prescribed for people living with dementia, including their risks and benefits and the importance of regular recorded reviews.
Learning Objectives
By the end of this session you will be able to:
- List the most common medications prescribed for people living with dementia
- Describe the main risks and benefits of using a range of anti-psychotics, antidepressants, anxiolytics, anticonvulsants and cognitive enhancers
- Recognise issues with regards to polypharmacy for people living with dementia
- Explain the importance of recording and reporting side-effects and/or adverse reactions to medication
- Describe how to administer and review medication safely and appropriately in consultation with people affected by dementia
This session will investigate the most common medications prescribed for people living with dementia, including their risks and benefits and the importance of regular recorded reviews.
This session has been mapped to the Dementia Training Standards Framework and is designed to support the Dementia Action Alliance Dementia Statements.


Before commencing this session you may wish to complete:
- Module 1 – Introduction to Living with Dementia/Dementia Awareness (407-0030)
Hadar is a Senior Lecture in Pharmacy at the University of Bradford and has worked at various NHS Mental Health service providers in his career. Hadar is currently the lead Pharmacist for Medicine Safety for one of the largest third sector organisations providing mental health services in the North West of England.
Hadar has a varied research background and has undertaken several systematic reviews which have been used to inform clinical guideline development nationally and internationally. Hadar, through his experience and practice, provides specialist professional and clinical advice to the Care Quality Commission and regularly participates in inspections. Hadar has worked on expert advisory groups for the Medicines and Healthcare products Regulatory Agency and is a member of The National Institute for Health and Care Excellence serving in the Centre for Guideline Development.

- Acute Medicine | Palliative care | Management of s...
- Posted By eIntegrity Healthcare e-Learning
- Posted Date: 2025-03-04
- Location:Online
- Acute seizure activity (also commonly known as convulsions) is one of the few situations considered a medical emergency for end of life care patients. It requires urgent intervention. This session provides a framework for the immediate management and long
- Acute Medicine | Palliative care | Management of p...
- Posted By eIntegrity Healthcare e-Learning
- Posted Date: 2025-03-04
- Location:Online
- As illness progresses in the last year of life, physical function inevitably diminishes. This session provides a framework for the management of physical deterioration of patients at the end of life. This session was reviewed by Sarah Hanrott and last upd
- Acute Medicine | Palliative care | Management of n...
- Posted By eIntegrity Healthcare e-Learning
- Posted Date: 2025-03-04
- Location:Online
- This session provides a framework for the drug and non-drug management of nausea and vomiting in end-of-life care. This session was reviewed by Sarah Hanrott and last updated in March 2024.
- Acute Medicine | Palliative care | Management of d...
- Posted By eIntegrity Healthcare e-Learning
- Posted Date: 2025-03-04
- Location:Online
- This session provides a framework for an integrated management of depression. It was reviewed by Felicity Wood and Sarah Hanrott and last updated in May 2023.
- Acute Medicine | Palliative care | Management of c...
- Posted By eIntegrity Healthcare e-Learning
- Posted Date: 2025-03-04
- Location:Online
- This session provides a framework for the drug and non-drug management of constipation in end-of-life care patients. This session was reviewed by Rachel Lee and was last updated in April 2023.